LONDON (Alliance News) - Life sciences company TyraTech Inc on Wednesday said it has secured a listing for its Vamousse head lice treatment with US pharmacy chain Walgreens Boots Alliance.
The listing comes after the company secured a deal with CVS, another US pharmacy chain, and Walmart.
It expects the Vamousse product to be rolled out to the majority of Walgreens stores in the US from May 2015.
"The Walgreens listing, following the recent CVS listing and the listing with Walmart last year will put our Vamousse head lice treatment in three of the top four pharmacy retailers in the USA," said TyraTech Chief Executive Officer Bruno Jactel.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
